z-logo
Premium
Establishment of Transplantation Tolerance via Minimal Conditioning in Aged Recipients
Author(s) -
Morison J. K.,
Homann J.,
Hammett M. V.,
Lister N.,
Layton D.,
Malin M. A.,
Thorburn A. N.,
Chidgey A. P.,
Boyd R. L.,
Heng T. S. P.
Publication year - 2014
Publication title -
american journal of transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.89
H-Index - 188
eISSN - 1600-6143
pISSN - 1600-6135
DOI - 10.1111/ajt.12929
Subject(s) - immune tolerance , medicine , immunosuppression , immune system , immunology , transplantation chimera , transplantation , bone marrow , haematopoiesis , progenitor cell , stem cell , cancer research , biology , microbiology and biotechnology , hematopoietic cell
Mixed hematopoietic chimerism is a powerful means of generating donor‐specific tolerance, allowing long‐term graft acceptance without lifelong dependence on immunosuppressive drugs. To avoid the need for whole body irradiation and associated side effects, we utilized a radiation‐free minimal conditioning regime to induce long‐term tolerance across major histocompatibility barriers. We found that low‐dose busulfan, in combination with host T cell depletion and short‐term sirolimus‐based immunosuppression, facilitated efficient donor engraftment. Tolerance was achieved when mice were transplanted with whole or T cell–depleted bone marrow, or purified progenitor cells. Tolerance induction was associated with an expansion in regulatory T cells and was not abrogated in the absence of a thymus, suggesting a dominant or compensatory peripheral mode of tolerance. Importantly, we were able to generate durable chimerism and tolerance to donor skin grafts in both young and aged mice, despite age‐related thymic atrophy and immune senescence. Clinically, this is especially relevant as the majority of transplant recipients are older patients whose immune recovery might be dangerously slow and would benefit from radiation‐free minimal conditioning regimes that allow efficient donor engraftment without fully ablating the recipient immune system.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here